Latest Conference

People living with HIV are twice as likely as those who do not have HIV to develop cardiovascular disease, yet recent data suggest this population does not meet recommended levels of physical activity.

There is a vast unmet need for non-pharmacological treatment strategies to protect and improve cognitive function in the approximately 50% of adults living with HIV who experience HIV-associated neurocognitive disorder.

A recent study suggests that smokers living with HIV were willing to transition to electronic cigarettes and had lower carbon monoxide levels after doing so.

San Francisco has seen HIV prevention and control success, however how people experiencing homelessness present unmet needs which require transforming traditional models of care.

The number of STI screenings increased exponentially from 369 rectal and pharyngeal swabs performed in 2015 prior to policy implementation to 865 swabs in 2016, 1474 swabs in 2017, and 1889 swabs in 2018.

The Cooper Early Intervention Program Expanded Care Clinic observed that the gap in retention in care among patients with HIV was reduced from 15% to 10% over a span of 3 months.

A team of investigators from Indiana University set out to examine levels of PrEP awareness among black men in a rural midwestern city to identify barriers and facilitators to PrEP uptake and access.

Among participants in the study arm, the app resulted in significant changes, particularly in fatigue intensity and overall fatigue-related functioning

Investigators at Northeastern conducted a trial that evaluated if a video series designed for the viewer to identify with characters and “transport” themselves into the storyline lead to an increase in HIV testing.

An online survey found that people living with HIV who had lower incomes are at a higher risk for household material hardships and poorer health outcomes.

Nurses stationed in public sexual health services and specialist HIV general physician practice study sites were integral in facilitating rapid PrEP uptake.

The Contagion® editorial staff will be providing exclusive written and video coverage from ANAC 2019.

Ryan K. Shields, PharmD, MS, reacts to research presented at IDWeek 2019 on cefiderocol versus high-dose meropenem for patients with nosocomial pneumonia.

A study by Shikha Garg, MD, MPH, and her team with the US Centers for Disease Control and Prevention boosts the evidence base for the benefit of influenza vaccination.

Max Brito, MD, MPH, discusses his presentation from IDWeek 2019 which compared HIV treatment in a community-based model versus a hospital-based model in Chicago.

Erin McCreary, PharmD, BCPS, BCIDP, shares her takeaways from IDWeek 2019.

Angela Campbell, MD, MPH, details a study on influenza vaccine effectiveness in children with respiratory illness.

Pavel Prusakov, PharmD, highlights how he educated pharmacists from South Africa to lead antimicrobial stewardship programs in the NICU with Pablo J. Sánchez, MD, and Debra Goff, PharmD.

Gregory Felzien, MD, AAHIVS, discusses barriers to HIV care, particularly in neglected rural areas.

Samuel L. Aitken, PharmD, MPH, shares the lessons learned from a case study on a patient with Stenotrophomonas maltophilia infection.

Elizabeth Hirsch, PharmD, and Delaney Hart, PharmD, discuss their poster at IDWeek 2019.

Debra Goff, PharmD, shares how the "Train-the-Trainer" program was implemented in South Africa with Pablo J. Sánchez, MD, and Pavel Prusakov, PharmD.

Deanna Buehrle, PharmD, discusses her study on bloodstream infections in solid organ transplant recipients.

Candidemia is the fourth most common health care-associated infection. To improve hospitalized patients’ safety, infectious disease physicians should be consulted.

Keith S. Kaye, MD, MPH, discusses the current treatment landscape for pneumonia in the ICU setting, and previews the topline results of the phase 3 RESTORE-IMI 2 trial.

Pablo J. Sánchez, MD, discusses the need for NICU stewardship with Debra Goff, PharmD, and Pavel Prusakov, PharmD.

Health officials provide 4 strategies to improve C auris surveillance efforts.

Newborn dried blood spot testing is not sensitive enough to diagnose all cases of congenital cytomegalovirus (cCMV) in infants with sensorineural hearing loss.